Patent · US Revoked

Polycyclic compounds as allosteric SHP2 inhibitors

US11634435B2 · kind B2 · utility

0Cited by
12References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 11, 2020
Grant dateApr 25, 2023
Priority date
Expiry dateJun 11, 2040

Classification

  • Technology area (CPC —)General

Abstract

The present disclosure is directed to inhibitors of SHP2 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.